Related Experiment Videos
Antigenic stimulation and multiple myeloma. A prospective study
1Division of Community Health Sciences, Northeastern Ohio Universities College of Medicine, Rootstown 44272.
Cancer
|October 1, 1993
Summary
Inflammatory conditions may increase the risk of developing multiple myeloma (MM). This prospective study found a higher rate ratio for MM with an increasing number of inflammatory conditions, suggesting a potential link.
Area of Science:
- Epidemiology
- Immunology
- Oncology
Background:
- Previous case reports suggested a link between antigenic conditions and multiple myeloma (MM).
- Controlled studies showed associations with individual conditions but lacked overall support for the hypothesis.
- A prospective cohort study was designed to test if immune-stimulating conditions are a risk factor for MM.
Purpose of the Study:
- To investigate the hypothesis that immune-stimulating conditions are a risk factor for multiple myeloma (MM).
- To analyze the association between various immune-stimulating conditions and the incidence of MM in a representative U.S. population cohort.
Main Methods:
- Utilized the First National Health and Nutrition Examination Survey cohort (14,407 participants) interviewed from 1971-1975.
- Ascertained vital status, cause of death, and hospitalizations from 1982-1986.
- Constructed risk factors from questionnaires: allergies, autoimmune conditions, chronic bacterial conditions, and inflammatory conditions.
Main Results:
- Eighteen cases of multiple myeloma (MM) were documented.
- The rate ratio (RR) for MM increased with the number of inflammatory conditions (RR=2.0 for one, RR=4.3 for two or more).
- MM risk increased with duration of inflammatory conditions (RR=1.6 per 10 years) and was significant with longer follow-up.
Conclusions:
- The prospective study design strengthens the findings regarding inflammatory conditions and multiple myeloma (MM) risk.
- Despite a small number of cases and potential exposure misclassification, results suggest a link.
- Further research may clarify the role of immune-stimulating conditions in MM development.